We are live on ! Find out more
ZTR

Virtus Total Return Fund

91 hedge funds and large institutions have $74.1M invested in Virtus Total Return Fund in 2026 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 27 increasing their positions, 24 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 24

6.25% more ownership

Funds ownership: 15.43%21.68% (+6.3%)

6% more capital invested

Capital invested by funds: $70.1M → $74.1M (+$4.08M)

0% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 15

1% less funds holding

Funds holding: 9291 (-1)

Holders
91
Holders Change
-1
Holders Change %
-1.09%
% of All Funds
0%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
15
Increased
27
Reduced
24
Closed
15
Calls
Puts
Net Calls
Net Calls Change

ZTR Hedge Fund Activity: Q2 2026 in Review

91 institutional investors reported a position in Virtus Total Return Fund (ZTR) for Q2 2026, worth a combined $74.1M — up 5.8% from $70.1M a quarter earlier.

Fund positioning in ZTR was balanced in Q2 2026: 15 funds opened new positions, 15 closed out, 27 added to existing stakes and 24 trimmed.

The largest buyer was Saba Capital Management, adding an estimated $5.42M. The largest seller was Karpus Investment Management, cutting an estimated $1.98M.

  • 91 institutional investors held Virtus Total Return Fund (ZTR) as of Q2 2026, down from 92 in Q1 2026.
  • Funds reported $74.1M of Virtus Total Return Fund stock for Q2 2026, up 5.8% quarter-over-quarter.
  • 15 funds opened new Virtus Total Return Fund positions in Q2 2026 and 15 closed out, a net change of 0 holders.
  • The largest Virtus Total Return Fund buyer in Q2 2026 was Saba Capital Management, an estimated $5.42M added.
  • The largest Virtus Total Return Fund seller in Q2 2026 was Karpus Investment Management, an estimated $1.98M sold.

Based on aggregated 13F filings for Q2 2026.